Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transplantation Sensor System with Myfortic in Adult Kidney Transplant Patients
2010-022406-41Phase 2Terminated
- Sponsor
- Novartis
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mycophenolate sodium in Kidney allograft status (RTx) and kidney failure, sponsored by Novartis. Primary endpoint: Device accuracy under directly observed ingestion. Started Aug 2011; status: terminated.
02
Drugs
mycophenolate sodium
03
Conditions
Kidney allograft status (RTx)kidney failure
Beyond the preview
Go deeper on 2010-022406-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022406-41.